ELOX
Eloxx Pharmaceuticals, Inc.Company with tickers: ELOX
CIK
1035354
CUSIP
29014R202
Shares Outstanding
7,573,935
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $1,222,000 | USD | 2025-03-31 | 10-Q | 2026-05-05 |
| Research & Development | — | ||||
| Operating Income | $-1,222,000 | USD | 2025-03-31 | 10-Q | 2026-05-05 |
| Net Income | $-1,709,000 | USD | 2025-03-31 | 10-Q | 2026-05-05 |
| EPS (Basic) | $-0.45 | USD/shares | 2025-03-31 | 10-Q | 2026-05-05 |
| EPS (Diluted) | $-0.45 | USD/shares | 2025-03-31 | 10-Q | 2026-05-05 |